Literature DB >> 9497244

Mapping of X-linked myxomatous valvular dystrophy to chromosome Xq28.

F Kyndt1, J J Schott, J N Trochu, F Baranger, O Herbert, V Scott, E Fressinaud, A David, J P Moisan, J B Bouhour, H Le Marec, B Bénichou.   

Abstract

Myxoid heart disease is frequently encountered in the general population. It corresponds to an etiologically heterogeneous group of diseases, idiopathic mitral valve prolapse (IMVP) being the most common form. A rarely observed form of myxoid heart disease, X-linked myxomatous valvular dystrophy (XMVD), is inherited in an X-linked fashion and is characterized by multivalvular myxomatous degeneration; however, the histopathological features of the mitral valve do not differ significantly from the severe form of IMVP. In this article, we describe the genetic analysis of a large family in which XMVD is associated with a mild hemophilia A. The coagulation factor VIII gene position in Xq28 provided a starting point for the genetic study, which was conducted by use of polymorphic markers. Two-point linkage analysis confirmed this localization, and a maximum LOD score of 6.57 was found at straight theta=0 for two polymorphic microsatellite markers, INT-3 and DXS1008, the first one being intronic to the factor VIII gene. Haplotype analysis of this chromosomal region allowed the definition of an 8-cM minimal interval containing the gene for XMVD, between DXS8011 and Xqter.

Entities:  

Mesh:

Year:  1998        PMID: 9497244      PMCID: PMC1376942          DOI: 10.1086/301747

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  24 in total

1.  Skewed X-chromosome inactivation in female carriers of dyskeratosis congenita.

Authors:  K Devriendt; G Matthijs; E Legius; E Schollen; D Blockmans; C van Geet; H Degreef; J J Cassiman; J P Fryns
Journal:  Am J Hum Genet       Date:  1997-03       Impact factor: 11.025

2.  Prolapse of the posterior leaflet of the mitral valve occurring in eleven members of a family.

Authors:  D Hunt; G Sloman
Journal:  Am Heart J       Date:  1969-08       Impact factor: 4.749

3.  Cardiac abnormalities in the Ehlers-Danlos syndrome.

Authors:  P Beighton
Journal:  Br Heart J       Date:  1969-03

4.  "Myxomatous" mitral valves: collagen dissolution as the primary defect.

Authors:  B D King; M A Clark; N Baba; J W Kilman; C F Wooley
Journal:  Circulation       Date:  1982-08       Impact factor: 29.690

5.  Mitral valve prolapse in the general population. 1. Epidemiologic features: the Framingham Study.

Authors:  D D Savage; R J Garrison; R B Devereux; W P Castelli; S J Anderson; D Levy; P M McNamara; J Stokes; W B Kannel; M Feinleib
Journal:  Am Heart J       Date:  1983-09       Impact factor: 4.749

6.  Report of the American Society of Echocardiography Committee on Nomenclature and Standards in Two-dimensional Echocardiography.

Authors:  W L Henry; A DeMaria; R Gramiak; D L King; J A Kisslo; R L Popp; D J Sahn; N B Schiller; A Tajik; L E Teichholz; A E Weyman
Journal:  Circulation       Date:  1980-08       Impact factor: 29.690

7.  Easy calculations of lod scores and genetic risks on small computers.

Authors:  G M Lathrop; J M Lalouel
Journal:  Am J Hum Genet       Date:  1984-03       Impact factor: 11.025

8.  Inheritance of mitral valve prolapse: effect of age and sex on gene expression.

Authors:  R B Devereux; W T Brown; R Kramer-Fox; I Sachs
Journal:  Ann Intern Med       Date:  1982-12       Impact factor: 25.391

9.  Mitral valve dysfunction in the Marfan syndrome. Clinical and echocardiographic study of prevalence and natural history.

Authors:  R E Pyeritz; M A Wappel
Journal:  Am J Med       Date:  1983-05       Impact factor: 4.965

10.  Deduced protein sequence of bone small proteoglycan I (biglycan) shows homology with proteoglycan II (decorin) and several nonconnective tissue proteins in a variety of species.

Authors:  L W Fisher; J D Termine; M F Young
Journal:  J Biol Chem       Date:  1989-03-15       Impact factor: 5.157

View more
  30 in total

1.  Toward an understanding of the cause of mitral valve prolapse.

Authors:  J A Towbin
Journal:  Am J Hum Genet       Date:  1999-11       Impact factor: 11.025

2.  A locus for autosomal dominant mitral valve prolapse on chromosome 11p15.4.

Authors:  Lisa A Freed; James S Acierno; Daisy Dai; Maire Leyne; Jane E Marshall; Francesca Nesta; Robert A Levine; Susan A Slaugenhaupt
Journal:  Am J Hum Genet       Date:  2003-04-21       Impact factor: 11.025

Review 3.  Degenerative mitral valve disease with emphasis on mitral valve prolapse.

Authors:  D Pellerin; S Brecker; C Veyrat
Journal:  Heart       Date:  2002-11       Impact factor: 5.994

Review 4.  Mitral valve disease--morphology and mechanisms.

Authors:  Robert A Levine; Albert A Hagége; Daniel P Judge; Muralidhar Padala; Jacob P Dal-Bianco; Elena Aikawa; Jonathan Beaudoin; Joyce Bischoff; Nabila Bouatia-Naji; Patrick Bruneval; Jonathan T Butcher; Alain Carpentier; Miguel Chaput; Adrian H Chester; Catherine Clusel; Francesca N Delling; Harry C Dietz; Christian Dina; Ronen Durst; Leticia Fernandez-Friera; Mark D Handschumacher; Morten O Jensen; Xavier P Jeunemaitre; Hervé Le Marec; Thierry Le Tourneau; Roger R Markwald; Jean Mérot; Emmanuel Messas; David P Milan; Tui Neri; Russell A Norris; David Peal; Maelle Perrocheau; Vincent Probst; Michael Pucéat; Nadia Rosenthal; Jorge Solis; Jean-Jacques Schott; Ehud Schwammenthal; Susan A Slaugenhaupt; Jae-Kwan Song; Magdi H Yacoub
Journal:  Nat Rev Cardiol       Date:  2015-10-20       Impact factor: 32.419

Review 5.  Basic mechanisms of mitral regurgitation.

Authors:  Jacob P Dal-Bianco; Jonathan Beaudoin; Mark D Handschumacher; Robert A Levine
Journal:  Can J Cardiol       Date:  2014-07-02       Impact factor: 5.223

Review 6.  Differentiating the aging of the mitral valve from human and canine myxomatous degeneration.

Authors:  Patrick S Connell; Richard I Han; K Jane Grande-Allen
Journal:  J Vet Cardiol       Date:  2012-02-24       Impact factor: 1.701

7.  Marfan syndrome and mitral valve prolapse.

Authors:  Arthur E Weyman; Marielle Scherrer-Crosbie
Journal:  J Clin Invest       Date:  2004-12       Impact factor: 14.808

8.  Filamin-A as a Balance between Erk/Smad Activities During Cardiac Valve Development.

Authors:  Katelynn Toomer; Kimberly Sauls; Diana Fulmer; Lilong Guo; Kelsey Moore; Janiece Glover; Rebecca Stairley; Joyce Bischoff; Robert A Levine; Russell A Norris
Journal:  Anat Rec (Hoboken)       Date:  2018-10-05       Impact factor: 2.064

9.  Developmental basis for filamin-A-associated myxomatous mitral valve disease.

Authors:  Kimberly Sauls; Annemarieke de Vlaming; Brett S Harris; Katherine Williams; Andy Wessels; Robert A Levine; Susan A Slaugenhaupt; Richard L Goodwin; Luigi Michele Pavone; Jean Merot; Jean-Jacques Schott; Thierry Le Tourneau; Thomas Dix; Sean Jesinkey; Yuanyi Feng; Christopher Walsh; Bin Zhou; Scott Baldwin; Roger R Markwald; Russell A Norris
Journal:  Cardiovasc Res       Date:  2012-07-25       Impact factor: 10.787

10.  Periostin induces intracellular cross-talk between kinases and hyaluronan in atrioventricular valvulogenesis.

Authors:  Shibnath Ghatak; Suniti Misra; Russell A Norris; Ricardo A Moreno-Rodriguez; Stanley Hoffman; Robert A Levine; Vincent C Hascall; Roger R Markwald
Journal:  J Biol Chem       Date:  2014-01-27       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.